1. Trial of tissue plasmittogeni activator t-or mortality rcductiout in acute tivocardial ifitarction. Antglo-Scandinavian study of carly thrombolysis ASSET);Wilcox, R.G.; Olsson, C.G.; Skcettc, A.M.; van der lippe G; Jcnsoni, G.; Hampton, JR;Lancet,1988
2. \ inccutR, Chamberlain L)A..\lultiplcmicroctiboli attcr disilntegration of clot during thrombolysis for acute myocardial infarction;StatfordPJ, StrachanCJl,1989
3. Gruppo ltaliano pr lo Streptochitiasi nell'Infarto,\liocardico# GISSI,1986
4. 'Iransient impairment ol renallunction after streptokinasc therapy;Pavne, S.T.; Hoskcr, H.S.R.; Allcn, M.I.B.; Bradbhrv, H.; I'age, R.L.;Lancti t,1989
5. Anisovlated I'lasmintgen Streptokinase Actixator Complcx Intervention Mortality Trial Study (iroup. Effect of intravenous AP'SAC on mortality after acuJte mvocardial infarction: preliminary report ot'a placebo-controlled clinical trial;Lancei,1988